InvestorsHub Logo
Followers 2
Posts 1274
Boards Moderated 0
Alias Born 08/09/2013

Re: SH1TFORBRAINS post# 6536

Thursday, 10/04/2018 1:41:21 PM

Thursday, October 04, 2018 1:41:21 PM

Post# of 7792
Your Very Humorous SFB

Remember Karma , & The slugs that shorts a cancer drug what it has in store for them ! It Has To Be Hot In That Boiler Room !

Its 181 Mil In cash and poss royalties form J&J under second licensing of patents. With a Fast track Last oct , Poss pending ??? and Poss In EU Approval ?? Regardless Of J&J Business Decision they sent out a very telling signal prior to walking, maybe deliberate ? "Imetelstat Was Approve For a Trial Drug Under "Compassionate Use " Anyone With a Brain Knows FDA Doesn't Pass Them Out !!! Imetelstat Had to Meet a Unmet Need and Certain Strictly Evaluated Criteria to be offered , Its apparent that J&J decision to move on and focus on other business had nothing to do with Imet ! Maybe they figured they have the second licensing agreement for patents and had no need for Geron to remain in first one !

There are a few near term catalyst that can make this a double for here, Or more ! JMHO GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News